The levels of most of G1, S and G2 cyclins, including cyclins D, E, and A were not changed by SKPin C1 treatment in both VHL-wildtype and deficient RCC cells (Supplementary Fig. S3A-B). This evidence concerns the gene VHL and renal cell carcinoma.